RxDoctor Payments Data

Daniel Kim

Radiation Oncology · Fairfax, VANPI 1437507274

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Teleflex LLC at 37.8% of the total. 2025 is the largest year on record at $261,180, more than ten times the $261 reported in 2021. Among radiation oncology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$405,931in general payments, 2019–2025

Across 492 payments — averaging $825.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$153K
  • Bioprotect Medical, Inc.$84K
  • Palette Life Sciences, Inc.$59K
  • GT Medical Technologies, Inc$49K
  • Novocure Inc.$41K
  • Novartis$7K
  • plus $13K from 21 others
$27,114in research payments, 2019–2025

Across 6 payments — averaging $4518.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GT Medical Technologies, Inc$27K

What the payments were for

  • Consulting fees$173,52143%
  • Speaking & faculty fees$179,53344%
  • Travel & lodging$19,0625%
  • Food & beverage$33,8158%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$405,931 in reported general payments places this provider in the 95th percentile of 121 radiation oncology providers in Virginia.

See all radiation oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$412,530
Medicare patients
538
Services billed
3,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl39$253

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →